http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021020920-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52ea112ca1da918407dd3d73846c6a3a |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-26 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56916 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate | 2020-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c9849dd10bb9f485537398ce38899f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34974910bd4858c0a27c58dbcc3f8a5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67673ce76172a632ddafbdc5e7d6d20e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2862e79de3f23709c2085308acc087d9 |
publicationDate | 2021-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2021020920-A2 |
titleOfInvention | Kit for predicting or diagnosing nonalcoholic fatty liver disease, and method for diagnosing nonalcoholic fatty liver disease |
abstract | The present invention relates to, with respect to nonalcoholic fatty liver disease, a kit for predicting or diagnosing the risk of the disease, a method for providing information for predicting or diagnosing the risk of the disease, a method for screening a therapeutic agent for the disease, and a pharmaceutical composition for prevention or treatment of the disease. More specifically, the kit for predicting or diagnosing may effectively predict and diagnose the risk of nonalcoholic fatty liver disease, with particularly excellent significance in prediction and information provision for non-obese subjects. Accordingly, the present invention may be effectively used in the prevention or treatment of the disease by providing effective information on nonalcoholic fatty liver disease through the kit. In addition, the pharmaceutical composition for prevention and treatment may be effectively used in the treatment of nonalcoholic fatty liver disease. |
priorityDate | 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.